Location History:
- Timonium, MD (US) (1998 - 2001)
- Timontown, MD (US) (2004 - 2010)
- Baltimore, MD (US) (2010)
- Lutherville, MD (US) (2001 - 2019)
Company Filing History:
14 out of 3,696 
1 out of 832,966 Years Active: 1998-2019
Title: **James Gordon Herman: Innovator in Cancer Detection**
Introduction
James Gordon Herman, located in Lutherville, MD, is a distinguished inventor with an impressive portfolio of 15 patents. His work primarily focuses on innovations in the field of cancer biology, particularly in the detection and prognosis of various cancers.
Latest Patents
Herman's most recent patents include groundbreaking methodologies in the area of DNA methylation. One notable patent, “DNA methylation markers and methods of use,” presents methods for identifying metastases through the detection of nucleic acid hypermethylation of specific genes in samples, notably lymph nodes. This invention is particularly significant as it relates to using DNA methylation as a predictor for disease recurrence and patient prognosis. Another key patent by Herman, titled “Compositions and methods for detecting a neoplasia,” focuses on identifying neoplasias such as pancreatic cancer, lung cancer, and colon cancer in subject samples including serum, blood, and tissue. This patent emphasizes the detection of BNC1 and ADAMTS1 promoter methylation in circulating DNA found in serum, showcasing his innovative approach to early cancer detection.
Career Highlights
Throughout his career, James Gordon Herman has contributed to significant advancements in cancer research. He has notably worked with renowned institutions, including The Johns Hopkins University, where he has had the opportunity to deepen his expertise in oncology and molecular biology. His extensive experience has cemented his reputation as a leading figure in cancer detection methods.
Collaborations
Collaboration has played a vital role in Herman’s innovations. He has worked with esteemed colleagues such as Stephen B. Baylin and Hiromu Suzuki, both of whom are recognized for their contributions in cancer biology and epigenetics. Their combined efforts have led to impactful research outcomes and advancements in the understanding of oncological processes.
Conclusion
James Gordon Herman stands out as a prominent inventor in the field of cancer detection, with a remarkable array of patents that reflect his dedication to improving patient outcomes. Through innovative methods and collaborative efforts, he continues to make significant contributions to the medical community, particularly in the realm of cancer biology. As research advances, Herman’s work will likely pave the way for more effective diagnostic and prognostic tools in oncology.